Juan D. Garcia-Mediavilla

Granada, AN, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Breakthrough LDL-C reduction in a patient with autosomal recessive homozygous familial hypercholesterolemia: Efficacy of evinacumab after LDL-apheresis discontinuation.

Breakthrough LDL-C reduction in a patient with autosomal recessive homozygous familial hypercholesterolemia: Efficacy of evinacumab after LDL-apheresis discontinuation.

Journal: Journal of clinical lipidology

Published: March 27, 2025

Real-world efficacy and safety of baroreceptor activation therapy in a series of patients with refractory arterial hypertension.

Real-world efficacy and safety of baroreceptor activation therapy in a series of patients with refractory arterial hypertension.

Journal: Hipertension y riesgo vascular

Published: October 07, 2024

Resilient Older Subjects with Heterozygous Familial Hypercholesterolemia, Baseline Differences and Associated Factors.

Resilient Older Subjects with Heterozygous Familial Hypercholesterolemia, Baseline Differences and Associated Factors.

Journal: International journal of molecular sciences

Published: March 25, 2024

Influence of triglyceride concentration in lipoprotein (a) as a function of dyslipidemia.

Influence of triglyceride concentration in lipoprotein (a) as a function of dyslipidemia.

Journal: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis

Published: October 07, 2023

Prescribing statin therapy in physically (in)active individuals vs prescribing physical activity in statin-treated patients: A four-scenario practical approach.

Prescribing statin therapy in physically (in)active individuals vs prescribing physical activity in statin-treated patients: A four-scenario practical approach.

Journal: Pharmacological research

Published: June 07, 2023

Concentration of low-density lipoproteins (LDL) is significantly reduced after nilotinib discontinuation.

Concentration of low-density lipoproteins (LDL) is significantly reduced after nilotinib discontinuation.

Journal: Scientific reports

Published: January 30, 2023

Persistent clinical manifestations at 3 and 6 months after severe acute respiratory syndrome coronavirus 2 infection.

Persistent clinical manifestations at 3 and 6 months after severe acute respiratory syndrome coronavirus 2 infection.

Journal: Medicina clinica (English ed.)

Published: April 25, 2022

Persistent clinical manifestations at 3 and 6 months after severe acute respiratory syndrome coronavirus 2 infection

Persistent clinical manifestations at 3 and 6 months after severe acute respiratory syndrome coronavirus 2 infection

Journal: Medicina clinica

Published: July 26, 2021

Arterial hypertension assessment in a population with chronic myeloid leukemia.

Arterial hypertension assessment in a population with chronic myeloid leukemia.

Journal: Scientific reports

Published: April 19, 2021

Dyslipidaemia in patients with haematology/oncology diseases.

Dyslipidaemia in patients with haematology/oncology diseases.

Journal: Endocrinologia, diabetes y nutricion

Published: February 17, 2021

Persistent symptoms after acute COVID-19 infection: importance of follow-up.

Persistent symptoms after acute COVID-19 infection: importance of follow-up.

Journal: Medicina clinica (English ed.)

Published: February 01, 2021

Persistent symptoms after acute COVID-19 infection: importance of follow-up

Persistent symptoms after acute COVID-19 infection: importance of follow-up

Journal: Medicina clinica

Published: July 19, 2020

Showing 1-12 of 27

Last Updated: 09/26/2026